Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SM 10906

Known as: SM-10906 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The newly synthesized prostaglandin (PG) I1 analogues, SM-10902 and SM-10906, were compared with PGE1 in terms of their… Expand
  • figure 2
  • figure 4
  • table 1
  • figure 5
  • figure 8
2000
2000
The present study investigated the effects of stable agonist for prostaglandin (PG) I2 receptor with PGI1 skeleton, SM-10906, on… Expand
1997
1997
Abstract The effects of prostaglandin (PG) I1, analog, SM‐10906 (SM‐6) and PGE1, on extracellular matrix formation and the… Expand
1997
1997
SM-10902 ((+)-methyl [2-[(2R,3aS,4R,5R,6aS)-octahydro-5-hydroxy-4-[(E)-(3S,5S)-3- hydroxy-5-methyl-1-nonenyl]-2-pentalenyl]ethoxy… Expand
1996
1996
Prostaglandins E1, prostaglandin E2, 3-oxa-methano-prostaglandin I1 (SM-10906), a stable prostaglandin I2 analog, and dibutyryl… Expand
1996
1996
The antithrombotic effect of topical application of the 3-oxa-methano-prostaglandin (PG) I1 analog, SM-10902 in the… Expand
1995
1995
The mechanism of the antiplatelet functions of SM-10906, the active form of the 3-oxa-methano-prostaglandin (PG) I1 analog SM… Expand
1994
1994
The prostacyclin I1 (PGI1) analogue, SM-10906 and its methyl ester, SM-10902, have been compared with the PGI2 analogue, iloprost… Expand
1994
1994
The pharmacological characteristics of the 3-oxamethano-prostaglandin I1 compound (+)-methyl [2-[(2R,3aS,4R,5R,6aS)-octahydro-5… Expand